Memorial Sloan Kettering Opens First Pediatric CAR T Cell Clinical Trial
Memorial Sloan Kettering Cancer CenterResearchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.